Association of PPARG rs3856806 C>T polymorphism with body mass index, glycaemia and lipid parameters in Serbian adolescents

  • Vanja Vidovic Department of Human Genetics, Faculty of Medicine, University of Banja Luka
  • Nela Maksimovic
  • Stojko Vidovic
  • Tatjana Damnjanovic
  • Ivana Novakovic
Keywords: PPARG, rs3856806, lipid profile, body mass index, fasting glucose level

Abstract


Background/Aim: Peroxisome proliferator-activated receptor gamma (PPARγ) belongs to a family of nuclear hormone receptors and ligand-activated transcription factors. PPARG gene is expressed in many tissues including adipose tissue where it plays a crucial role in differentiation of adipocyte, insulin resistance, blood glucose levels and lipid metabolism. The aim of the study was to examine the association of rs3856806 polymorphism with the body mass index (BMI), fasting glucose levels and lipid parameters in Serbian adolescents.

Methods: This research included 287 adolescents of both genders (143 boys and 144 girls), 14-15 years of age. Genotype detection was done by polymerase chain reaction-restriction fragment length polymorphism (RFLP) assay.

Results: Results showed statistically significant difference in terms of fasting glucose levels among girls (p = 0.013) depending on their genotype. Female carriers of CC genotype had significantly higher level of fasting glucose levels. Also, results showed that in the group of overweight and obese girls, carriers of CT or TT genotype had statistically significant lower values of HDL cholesterol compared to girls - carriers of CC genotype (p = 0.000). However, this result was not confirmed by multiple regression analysis. Statistically significant association of rs3856806 polymorphism was not observed with BMI nor with other lipid parameters.

Conclusion: This polymorphism is associated with fasting glucose level and HDL cholesterol among girls. To draw definite conclusions, further research should be conducted including non-genetic factors and other polymorphisms among this gene.

References

Yanovski JA. Pediatric obesity: An introduction. Appetite. 2015;93:3–12.
2. Srivastava G, Fox CK, Kelly AS, Jastreboff AM, Browne AF, Browne NT, et al. Clinical Considerations Regarding the Use of Obesity Pharmacotherapy in Adolescents with Obesity. Obesity. 2019;27(2):190–204.
3. Skledar M, Nikolac M, Dodig-Curkovic K, Curkovic M, Borovecki F, Pivac N. Association between brain-derived neurotrophic factor Val66Met and obesity in children and adolescents. Prog Neuro-Psychopharmacology Biol Psychiatry. 2012;36(1):136–40.
4. Garcia CA, Van Nostrand D, Atkins F, Acio E, Butler C, Esposito G, et al. Reduction of brown fat 2-deoxy-2-[F-18]fluoro-D-glucose uptake by controlling environmental temperature prior to positron emission tomography scan. Mol Imaging Biol. 2006;8(1):24–9.
5. Sharp LZ, Shinoda K, Ohno H, Scheel DW, Tomoda E, Ruiz L, et al. Human BAT Possesses Molecular Signatures That Resemble Beige/Brite Cells. PLoS One. 2012;7(11):e49452.
6. Gilsanz V, Smith ML, Goodarzian F, Kim M, Wren T, Hu HH. Changes in brown adipose tissue in boys and girls during childhood and puberty. J Pediatr. 2012;160:604–9.
7. Hioki C, Yoshida T, Kogure A, Takakura Y, Umekawa T, Yoshioka K, et al. Effects of growth hormone (GH) on mRNA levels of uncoupling proteins 1, 2, and 3 in brown and white adipose tissues and skeletal muscle in obese mice. Horm Metab Res. 2004;36(9):607–13.
8. Rodriguez-Cuenca S, Monjo M, Frontera M, Gianotti M, Proenza AM, Roca P. Sex steroid receptor expression profile in brown adipose tissue. Effects of hormonal status. Cell Physiol Biochem. 2007;20(6):877–86.
9. Chondronikola M, Volpi E, Børsheim E, Porter C, Saraf MK, Annamalai P, et al. Brown Adipose Tissue Activation Is Linked to Distinct Systemic Effects on Lipid Metabolism in Humans. Cell Metab. 2016;23(6):1200–6.
10. Matsushita M, Yoneshiro T, Aita S, Kameya T, Sugie H, Saito M. Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans. Int J Obes. 2014;38(6):812–7.
11. Ozguven S, Ones T, Yilmaz Y, Turoglu HT, Imeryuz N. The role of active brown adipose tissue in human metabolism. Eur J Nucl Med Mol Imaging. 2016;43(2):355–61.
12. Villanueva CJ, Vergnes L, Wang J, Drew BG, Hong C, Tu Y, et al. Adipose subtype-selective recruitment of TLE3 or Prdm16 by PPARγ specifies lipid storage versus thermogenic gene programs. Cell Metab. 2013;17(3):423–35.
13. Farmer SR. Transcriptional control of adipocyte formation. Cell Metab. 2006;4(4):263–73.
14. Tyagi S, Gupta P, Saini A, Kaushal C, Sharma S. The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011;2(4):236–240.
15. Seale P, Kajimura S, Yang W, Chin S, Rohas LM, Uldry M, et al. Transcriptional Control of Brown Fat Determination by PRDM16. Cell Metab. 2007;6(1):38–54.
16. Ahmadian M, Suh JM, Hah N, Liddle C, Atkins AR, Downes M, et al. PPARγ signaling and metabolism: the good, the bad and the future. Nat Med. 2013;19(5):557–66.
17. Corrales P, Vidal-Puig A, Medina-Gómez G. PPARS and metabolic disorders associated with challenged adipose tissue plasticity. Int J Mol Sci. 2018;19(7):2124.
18. Pap A, Cuaranta-Monroy I, Peloquin M, Nagy L. Is the mouse a good model of human PPARγ-related metabolic diseases? Int J Mol Sci. 2016;17(8):1–22.
19. Kim HJ, Lee SY, Kim CM. Association between gene polymorphisms and obesity and physical fitness in Korean children. Biol Sport. 2018;35(1):21–7.
20. Tan LJ, Zhu H, He H, Wu KH, Li J, Chen XD, et al. Replication of 6 obesity genes in a meta-analysis of genome-wide association studies from diverse ancestries. PLoS One. 2014;9(5):e96149.
21. Majkic-Singh N, Ilic M, Jankovic O, Ignjatovic S, Obradovic I. Trendovi u nalazima lipidnih frakcija u JUSAD studiji. In: Nedeljkovic S, Simeunovic S, Vukotic M, editors. Jugoslovenska studija prekursora ateroskleroze kod skolske dece. Belgrade: Faculty of Medicine, Belgrade University; 2006. p. 529.
22. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16(3):1215.
23. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499–502.
24. Gilsanz V, Smith ML, Goodarzian F, Kim M, Wren TAL, Hu HH. Changes in brown adipose tissue in boys and girls during childhood and puberty. J Pediatr. 2012;160(4):1–3.
25. Cao L, Choi EY, Liu X, Martin A, Wang C, Xu X, et al. White to brown fat phenotypic switch induced by genetic and environmental activation of a hypothalamic-adipocyte axis. Cell Metab. 2011;14(3):324–38.
26. Rockstroh D, Landgraf K, Wagner IV, Gesing J, Tauscher R, Lakowa N, et al. Direct evidence of brown adipocytes in different fat depots in children. PLoS One. 2015;10(2):1–17.
27. León-Mimila P, Villamil-Ramírez H, Villalobos-Comparán M, Villarreal-Molina T, Romero-Hidalgo S, López-Contreras B, et al. Contribution of Common Genetic Variants to Obesity and Obesity-Related Traits in Mexican Children and Adults. PLoS One. 2013;8(8):e70640.
28. Luo W, Guo Z, Wu M, Hao C, Hu X, Zhou Z, et al. Association of peroxisome proliferator-activated receptor α/δ/γ with obesity, and gene-gene interaction, in the chinese han population. J Epidemiol. 2013;23(3):187–94.
29. Parra EJ, Hoggart CJ, Bonilla C, Dios S, Norris JM, Marshall JA, et al. Relation of type 2 diabetes to individual admixture and candidate gene polymorphisms in the Hispanic American population of San Luis Valley, Colorado. J Med Genet. 2004;41(11):e116.
30. Burt Solorzano CM, McCartney CR. Obesity and the pubertal transition in girls and boys. Reproduction. 2010;140(3):399–410.
31. Aranđelović D, Marjanović B, Bokonjić J, Grujić-Ilić G. Uticaj fizičke aktivnosti na profil lipida seruma i glikemije i rizik za razvoj ateroskleroze u adolescenata. Sport Med. 2004;4(1):4–11.
32. We WM, Wu XY, Li ST, Shen Q. PPARG gene C161T CT/TT associated with lower blood lipid levels and ischemic stroke from large-artery atherosclerosis in a Han population in Guangdong. Neurol Res. 2016;38(7):620–4.
33. Butt H, Shabana, Hasnain S. The C1431T polymorphism of peroxisome proliferator activated receptor γ (PPARγ) is associated with low risk of diabetes in a Pakistani cohort. Diabetol Metab Syndr. 2016;8(1):4–9.
34. Fan W, Shen C, Wu M, Zhou ZY, Guo ZR. Association and Interaction of PPARα, δ, and γ Gene Polymorphisms with Low-Density Lipoprotein-Cholesterol in a Chinese Han Population. Genet Test Mol Biomarkers. 2015;19(7):379–86.
35. Dujić T, Bego T, Mlinar B, Semiz S, Malenica M, Prnjavorac B, et al. Effects of the PPARG gene polymorphisms on markers of obesity and the metabolic syndrome in Bosnian subjects. J Med Biochem. 2014;33(4):323–32.
36. Zhou X, Chen J, Xu W. Association between C1431T polymorphism in peroxisome proliferator- activated receptor-γ gene and coronary artery disease in Chinese Han population. Mol Biol Rep. 2012;39(2):1863–8.
37. Grygiel-Górniak B, Mosor M, Marcinkowska J, Przysławski J, Nowak J. Impact of the PPAR gamma-2 gene polymorphisms on the metabolic state of postmenopausal women. J Biosci. 2016;41(3):427–37.
Published
2021/03/26
Section
Original article